Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis.
Journal
European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
03
10
2020
accepted:
17
12
2020
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
25
11
2021
Statut:
epublish
Résumé
Pulmonary hypertension (PH) is a frequent complication in patients with COPD. To determine if, in patients with COPD, the presence of PH decreases exercise tolerance. We included studies that analysed exercise tolerance using a cardiopulmonary exercise test (CPET) in patients with COPD with PH (COPD-PH) and without PH (COPD-nonPH). Two independent reviewers analysed the studies, extracted the data and assessed the quality of the evidence. Of the 4915 articles initially identified, seven reported 257 patients with COPD-PH and 404 patients with COPD-nonPH. The COPD-PH group showed differences in peak oxygen consumption ( Exercise tolerance was significantly lower in patients with COPD-PH than in patients with COPD-nonPH, particularly in nontransplant candidates.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary hypertension (PH) is a frequent complication in patients with COPD.
OBJECTIVE
OBJECTIVE
To determine if, in patients with COPD, the presence of PH decreases exercise tolerance.
METHODS
METHODS
We included studies that analysed exercise tolerance using a cardiopulmonary exercise test (CPET) in patients with COPD with PH (COPD-PH) and without PH (COPD-nonPH). Two independent reviewers analysed the studies, extracted the data and assessed the quality of the evidence.
RESULTS
RESULTS
Of the 4915 articles initially identified, seven reported 257 patients with COPD-PH and 404 patients with COPD-nonPH. The COPD-PH group showed differences in peak oxygen consumption (
CONCLUSION
CONCLUSIONS
Exercise tolerance was significantly lower in patients with COPD-PH than in patients with COPD-nonPH, particularly in nontransplant candidates.
Identifiants
pubmed: 33927006
pii: 30/160/200321
doi: 10.1183/16000617.0321-2020
pmc: PMC9489125
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©The authors 2021.
Déclaration de conflit d'intérêts
Conflict of interest: R. Torres-Castro has nothing to disclose. Conflict of interest: E. Gimeno-Santos has nothing to disclose. Conflict of interest: J. Vilaró has nothing to disclose. Conflict of interest: M. Roqué-Figuls has nothing to disclose. Conflict of interest: J. Moisés has nothing to disclose. Conflict of interest: L. Vasconcello-Castillo has nothing to disclose. Conflict of interest: T. Orizaga has nothing to disclose. Conflict of interest: J.A. Barberà has nothing to disclose. Conflict of interest: I. Blanco has nothing to disclose.
Références
Eur J Prev Cardiol. 2012 Feb;19(1):32-40
pubmed: 21450614
Eur Respir J. 2013 May;41(5):1031-41
pubmed: 22903957
Chest. 2012 Nov;142(5):1166-1174
pubmed: 22556320
J Heart Lung Transplant. 2012 Apr;31(4):373-80
pubmed: 22226804
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S53-S58
pubmed: 28362512
Circulation. 2001 Jul 24;104(4):429-35
pubmed: 11468205
Int J Chron Obstruct Pulmon Dis. 2019 Nov 20;14:2543-2551
pubmed: 31819392
Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):499-505
pubmed: 31771920
BMC Pulm Med. 2018 Aug 23;18(1):143
pubmed: 30139350
J Am Soc Echocardiogr. 2012 Mar;25(3):280-6
pubmed: 22230250
Int J Chron Obstruct Pulmon Dis. 2017 Dec 22;13:91-100
pubmed: 29339921
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Chest. 2004 Jul;126(1 Suppl):14S-34S
pubmed: 15249493
Med Sci Sports Exerc. 2008 Oct;40(10):1725-32
pubmed: 18799981
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545980
Respir Med. 2010 Dec;104(12):1877-82
pubmed: 20547449
Respirology. 2016 Aug;21(6):984-94
pubmed: 27028849
N Engl J Med. 2012 Sep 6;367(10):913-21
pubmed: 22938715
Respir Med. 2010 Jan;104(1):121-6
pubmed: 19577458
Heart Lung Circ. 2014 Sep;23(9):833-40
pubmed: 24793962
BMJ. 2019 Jan 30;364:k4597
pubmed: 30700442
Eur Respir J. 2019 May 18;53(5):
pubmed: 30846476
Int J Chron Obstruct Pulmon Dis. 2015 Jul 14;10:1313-20
pubmed: 26203238
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S84-S92
pubmed: 28375670
Arq Bras Cardiol. 2016 Nov;107(5):467-481
pubmed: 27982272
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Chest. 2007 Dec;132(6):1778-85
pubmed: 17925409
Eur Respir J. 1997 Nov;10(11):2662-89
pubmed: 9426113
Circulation. 2011 Feb 15;123(6):668-80
pubmed: 21321183
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Respiration. 2008;76(2):160-7
pubmed: 17960052
Lung. 2015 Apr;193(2):223-9
pubmed: 25749664
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011
pubmed: 29746142
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Br J Pharmacol. 2021 Jan;178(1):132-151
pubmed: 31976545
Heart. 2011 Apr;97(8):612-22
pubmed: 21357375